TY - JOUR
AU - X. Li
AU - D. Shorter
AU - T. R. Kosten
A1 - 
AB - As a result of the prescription opioid epidemic in the United States, there has been an increasing need for effective treatment interventions, both pharmacological and nonpharmacological. Buprenorphine has emerged as a critical component of the treatment of opioid use disorder, yet its adoption has not been without some concerns. This article first reviews the pharmacology, clinical use, and US legislative action related to buprenorphine, followed by a discussion of the misuse and diversion of buprenorphine in the United States as well as internationally. We then explore the impact of buprenorphine abuse as well as discussing strategies for its reduction, including changes in policy, prescription and pharmacy monitoring, and continuing medical education for guiding and improving clinical practice.
BT - Journal of psychiatric practice
C5 - Opioids & Substance Use; Education & Workforce
CP - 3
CY - United States
DO - 10.1097/PRA.0000000000000154
IS - 3
JF - Journal of psychiatric practice
N2 - As a result of the prescription opioid epidemic in the United States, there has been an increasing need for effective treatment interventions, both pharmacological and nonpharmacological. Buprenorphine has emerged as a critical component of the treatment of opioid use disorder, yet its adoption has not been without some concerns. This article first reviews the pharmacology, clinical use, and US legislative action related to buprenorphine, followed by a discussion of the misuse and diversion of buprenorphine in the United States as well as internationally. We then explore the impact of buprenorphine abuse as well as discussing strategies for its reduction, including changes in policy, prescription and pharmacy monitoring, and continuing medical education for guiding and improving clinical practice.
PP - United States
PY - 2016
SN - 1538-1145; 1527-4160
SP - 183
EP - 192
EP - 
T1 - Buprenorphine Prescribing: To Expand or Not to Expand
T2 - Journal of psychiatric practice
TI - Buprenorphine Prescribing: To Expand or Not to Expand
U1 - Opioids & Substance Use; Education & Workforce
U2 - 27123798
U3 - 10.1097/PRA.0000000000000154
VL - 22
VO - 1538-1145; 1527-4160
Y1 - 2016
ER -